Risk-informed Siting of Major Hazard Infrastructure Using Spatio-temporal Multi-criteria Decision Analysis
The Sydney Journal of Interdisciplinary Engineering · 18.11.2026 · 2 (2) · 213-220
DOI: 10.30722/0q3zf077 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Sydney Journal of Interdisciplinary Engineering, online erschienen am 18.11.2026.
Abstract (Originalsprache)
This study presents a transferable multi-criteria decision analysis (MCDA) framework for screening candidate locations for Major Hazard Facility (MHF) placement. Nine spatial criteria are integrated through a weighted suitability expression applied to a 1 km raster grid. The framework is demonstrated using Western Sydney as a proof-of-concept study area, drawing on eleven spatial and temporal datasets from NSW government portals, the ABS, and the Bureau of Meteorology. A base case reflecting current regulatory guidance is compared against three scenarios: increased bushfire weighting informed by observed climate trends, projected population growth to 2046, and a combined scenario. Results show suitability ranking is sensitive to both hazard exposure and population growth over time, revealing a direct tension between fire-safe and population-distant siting. The framework is a screening tool for surfacing such trade-offs, not a definitive siting decision.
Zitieren
APA
(2026). Risk-informed Siting of Major Hazard Infrastructure Using Spatio-temporal Multi-criteria Decision Analysis. The Sydney Journal of Interdisciplinary Engineering, 2(2), 213-220. https://doi.org/10.30722/0q3zf077
Vancouver
Risk-informed Siting of Major Hazard Infrastructure Using Spatio-temporal Multi-criteria Decision Analysis. The Sydney Journal of Interdisciplinary Engineering. 2026;2(2):213-220. doi:10.30722/0q3zf077
BibTeX
@article{euvimed2026,
title = {Risk-informed Siting of Major Hazard Infrastructure Using Spatio-temporal Multi-criteria Decision Analysis},
journal = {The Sydney Journal of Interdisciplinary Engineering},
year = {2026},
volume = {2},
number = {2},
pages = {213--220},
doi = {10.30722/0q3zf077}
}
EUVIMED